NYSEAMERICAN:APT

Alpha Pro Tech Competitors

$9.52
-0.05 (-0.52 %)
(As of 04/20/2021 11:52 AM ET)
Add
Compare
Today's Range
$9.36
Now: $9.52
$9.60
50-Day Range
$11.15
MA: $12.00
$12.62
52-Week Range
$9.05
Now: $9.52
$25.55
Volume8,480 shs
Average Volume943,742 shs
Market Capitalization$129.44 million
P/E Ratio6.52
Dividend YieldN/A
Beta-1.27

Competitors

Alpha Pro Tech (NYSEAMERICAN:APT) Vs. SIEN, IVC, LAKE, SMTI, UEEC, and SRGA

Should you be buying APT stock or one of its competitors? Companies in the industry of "surgical appliances & supplies" are considered alternatives and competitors to Alpha Pro Tech, including Sientra (SIEN), Invacare (IVC), Lakeland Industries (LAKE), Sanara MedTech (SMTI), United Health Products (UEEC), and Surgalign (SRGA).

Alpha Pro Tech (NYSEAMERICAN:APT) and Sientra (NASDAQ:SIEN) are both small-cap industrial products companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability.

Risk and Volatility

Alpha Pro Tech has a beta of -1.27, suggesting that its stock price is 227% less volatile than the S&P 500. Comparatively, Sientra has a beta of 1.81, suggesting that its stock price is 81% more volatile than the S&P 500.

Earnings & Valuation

This table compares Alpha Pro Tech and Sientra's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Pro Tech$46.67 million2.77$3 million$0.2341.39
Sientra$83.70 million4.55$-106,820,000.00($2.29)-2.90

Alpha Pro Tech has higher earnings, but lower revenue than Sientra. Sientra is trading at a lower price-to-earnings ratio than Alpha Pro Tech, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

38.2% of Alpha Pro Tech shares are owned by institutional investors. Comparatively, 71.0% of Sientra shares are owned by institutional investors. 10.6% of Alpha Pro Tech shares are owned by company insiders. Comparatively, 2.8% of Sientra shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Alpha Pro Tech and Sientra's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Alpha Pro Tech23.65%45.69%36.95%
Sientra-123.88%-174.05%-38.97%

Analyst Ratings

This is a summary of current recommendations for Alpha Pro Tech and Sientra, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Alpha Pro Tech00103.00
Sientra00403.00

Alpha Pro Tech currently has a consensus target price of $32.50, suggesting a potential upside of 243.19%. Sientra has a consensus target price of $10.00, suggesting a potential upside of 50.38%. Given Alpha Pro Tech's higher possible upside, equities research analysts clearly believe Alpha Pro Tech is more favorable than Sientra.

Summary

Alpha Pro Tech beats Sientra on 8 of the 13 factors compared between the two stocks.

Alpha Pro Tech (NYSEAMERICAN:APT) and Invacare (NYSE:IVC) are both small-cap industrial products companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and profitability.

Risk & Volatility

Alpha Pro Tech has a beta of -1.27, indicating that its share price is 227% less volatile than the S&P 500. Comparatively, Invacare has a beta of 0.94, indicating that its share price is 6% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Alpha Pro Tech and Invacare, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Alpha Pro Tech00103.00
Invacare00103.00

Alpha Pro Tech presently has a consensus price target of $32.50, suggesting a potential upside of 243.19%. Invacare has a consensus price target of $17.00, suggesting a potential upside of 100.24%. Given Alpha Pro Tech's higher probable upside, equities research analysts plainly believe Alpha Pro Tech is more favorable than Invacare.

Insider & Institutional Ownership

38.2% of Alpha Pro Tech shares are held by institutional investors. Comparatively, 96.7% of Invacare shares are held by institutional investors. 10.6% of Alpha Pro Tech shares are held by insiders. Comparatively, 3.2% of Invacare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares Alpha Pro Tech and Invacare's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Pro Tech$46.67 million2.77$3 million$0.2341.39
Invacare$927.96 million0.31$-53,330,000.00($1.06)-7.95

Alpha Pro Tech has higher earnings, but lower revenue than Invacare. Invacare is trading at a lower price-to-earnings ratio than Alpha Pro Tech, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Alpha Pro Tech and Invacare's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Alpha Pro Tech23.65%45.69%36.95%
Invacare-4.87%-8.76%-3.07%

Summary

Alpha Pro Tech beats Invacare on 9 of the 12 factors compared between the two stocks.

Lakeland Industries (NASDAQ:LAKE) and Alpha Pro Tech (NYSEAMERICAN:APT) are both small-cap industrial products companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, risk, dividends, institutional ownership and profitability.

Analyst Ratings

This is a summary of current ratings and recommmendations for Lakeland Industries and Alpha Pro Tech, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Lakeland Industries00203.00
Alpha Pro Tech00103.00

Lakeland Industries currently has a consensus price target of $37.00, suggesting a potential upside of 32.95%. Alpha Pro Tech has a consensus price target of $32.50, suggesting a potential upside of 243.19%. Given Alpha Pro Tech's higher probable upside, analysts plainly believe Alpha Pro Tech is more favorable than Lakeland Industries.

Earnings and Valuation

This table compares Lakeland Industries and Alpha Pro Tech's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Lakeland Industries$107.81 million2.07$3.28 million$0.4561.84
Alpha Pro Tech$46.67 million2.77$3 million$0.2341.39

Lakeland Industries has higher revenue and earnings than Alpha Pro Tech. Alpha Pro Tech is trading at a lower price-to-earnings ratio than Lakeland Industries, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Lakeland Industries and Alpha Pro Tech's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Lakeland Industries18.93%28.75%24.67%
Alpha Pro Tech23.65%45.69%36.95%

Risk & Volatility

Lakeland Industries has a beta of 0.03, suggesting that its share price is 97% less volatile than the S&P 500. Comparatively, Alpha Pro Tech has a beta of -1.27, suggesting that its share price is 227% less volatile than the S&P 500.

Institutional and Insider Ownership

70.8% of Lakeland Industries shares are owned by institutional investors. Comparatively, 38.2% of Alpha Pro Tech shares are owned by institutional investors. 4.9% of Lakeland Industries shares are owned by insiders. Comparatively, 10.6% of Alpha Pro Tech shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Lakeland Industries beats Alpha Pro Tech on 7 of the 13 factors compared between the two stocks.

Sanara MedTech (NASDAQ:SMTI) and Alpha Pro Tech (NYSEAMERICAN:APT) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, analyst recommendations, profitability, institutional ownership and risk.

Insider and Institutional Ownership

38.2% of Alpha Pro Tech shares are held by institutional investors. 78.4% of Sanara MedTech shares are held by company insiders. Comparatively, 10.6% of Alpha Pro Tech shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Volatility and Risk

Sanara MedTech has a beta of 2.43, indicating that its stock price is 143% more volatile than the S&P 500. Comparatively, Alpha Pro Tech has a beta of -1.27, indicating that its stock price is 227% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and price targets for Sanara MedTech and Alpha Pro Tech, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Sanara MedTech0000N/A
Alpha Pro Tech00103.00

Alpha Pro Tech has a consensus target price of $32.50, indicating a potential upside of 243.19%. Given Alpha Pro Tech's higher probable upside, analysts clearly believe Alpha Pro Tech is more favorable than Sanara MedTech.

Earnings & Valuation

This table compares Sanara MedTech and Alpha Pro Tech's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sanara MedTech$11.77 million18.01$-2,810,000.00N/AN/A
Alpha Pro Tech$46.67 million2.77$3 million$0.2341.39

Alpha Pro Tech has higher revenue and earnings than Sanara MedTech.

Profitability

This table compares Sanara MedTech and Alpha Pro Tech's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Sanara MedTech-39.58%-175.36%-55.40%
Alpha Pro Tech23.65%45.69%36.95%

Summary

Alpha Pro Tech beats Sanara MedTech on 9 of the 12 factors compared between the two stocks.

United Health Products (OTCMKTS:UEEC) and Alpha Pro Tech (NYSEAMERICAN:APT) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, earnings and risk.

Profitability

This table compares United Health Products and Alpha Pro Tech's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
United Health ProductsN/AN/A-8,666.57%
Alpha Pro Tech23.65%45.69%36.95%

Insider and Institutional Ownership

0.6% of United Health Products shares are owned by institutional investors. Comparatively, 38.2% of Alpha Pro Tech shares are owned by institutional investors. 10.6% of Alpha Pro Tech shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Valuation and Earnings

This table compares United Health Products and Alpha Pro Tech's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
United Health ProductsN/AN/A$-6,600,000.00N/AN/A
Alpha Pro Tech$46.67 million2.77$3 million$0.2341.39

Alpha Pro Tech has higher revenue and earnings than United Health Products.

Risk and Volatility

United Health Products has a beta of -0.26, indicating that its share price is 126% less volatile than the S&P 500. Comparatively, Alpha Pro Tech has a beta of -1.27, indicating that its share price is 227% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for United Health Products and Alpha Pro Tech, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
United Health Products0000N/A
Alpha Pro Tech00103.00

Alpha Pro Tech has a consensus price target of $32.50, suggesting a potential upside of 243.19%. Given Alpha Pro Tech's higher possible upside, analysts clearly believe Alpha Pro Tech is more favorable than United Health Products.

Summary

Alpha Pro Tech beats United Health Products on 10 of the 11 factors compared between the two stocks.

Alpha Pro Tech (NYSEAMERICAN:APT) and Surgalign (NASDAQ:SRGA) are both small-cap industrial products companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, earnings, profitability, valuation, risk, institutional ownership and dividends.

Risk & Volatility

Alpha Pro Tech has a beta of -1.27, meaning that its share price is 227% less volatile than the S&P 500. Comparatively, Surgalign has a beta of 2.21, meaning that its share price is 121% more volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and target prices for Alpha Pro Tech and Surgalign, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Alpha Pro Tech00103.00
Surgalign00403.00

Alpha Pro Tech presently has a consensus price target of $32.50, indicating a potential upside of 243.19%. Surgalign has a consensus price target of $4.3333, indicating a potential upside of 147.62%. Given Alpha Pro Tech's higher probable upside, equities analysts clearly believe Alpha Pro Tech is more favorable than Surgalign.

Earnings and Valuation

This table compares Alpha Pro Tech and Surgalign's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Pro Tech$46.67 million2.77$3 million$0.2341.39
Surgalign$308.38 million0.64$-211,640,000.00($0.16)-11.13

Alpha Pro Tech has higher earnings, but lower revenue than Surgalign. Surgalign is trading at a lower price-to-earnings ratio than Alpha Pro Tech, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Alpha Pro Tech and Surgalign's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Alpha Pro Tech23.65%45.69%36.95%
Surgalign-56.07%-101.34%-18.44%

Insider & Institutional Ownership

38.2% of Alpha Pro Tech shares are held by institutional investors. Comparatively, 53.5% of Surgalign shares are held by institutional investors. 10.6% of Alpha Pro Tech shares are held by company insiders. Comparatively, 3.7% of Surgalign shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Alpha Pro Tech beats Surgalign on 9 of the 13 factors compared between the two stocks.


Alpha Pro Tech Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Sientra logo
SIEN
Sientra
1.6$6.65-3.0%$392.32 million$83.70 million-3.74Increase in Short Interest
News Coverage
Invacare logo
IVC
Invacare
1.6$8.43-0.2%$290.88 million$927.96 million-6.85
Lakeland Industries logo
LAKE
Lakeland Industries
1.8$27.83-0.6%$224.48 million$107.81 million7.91Earnings Announcement
Analyst Upgrade
SMTI
Sanara MedTech
0.8$27.83-0.3%$212.59 million$11.77 million-21.57Decrease in Short Interest
News Coverage
United Health Products logo
UEEC
United Health Products
1.0$0.91-2.6%$205.54 millionN/A-15.16
Surgalign logo
SRGA
Surgalign
1.7$1.78-2.2%$200.69 million$308.38 million-0.99Increase in Short Interest
Surgalign logo
SRGA
Surgalign
1.4$1.78-2.2%$200.69 million$308.38 million-0.99Increase in Short Interest
Milestone Scientific logo
MLSS
Milestone Scientific
1.3$2.36-7.6%$169.06 million$8.38 million-14.75
Conformis logo
CFMS
Conformis
1.3$0.81-4.9%$155.43 million$77.43 million-2.39News Coverage
Gap Up
Nutriband logo
NTRB
Nutriband
0.7$15.00-39.9%$95.34 million$370,000.00-50.00Gap Up
CollPlant Biotechnologies logo
CLGN
CollPlant Biotechnologies
1.1$13.99-3.6%$82.16 million$2.32 million-7.00
ReWalk Robotics logo
RWLK
ReWalk Robotics
1.4$1.73-2.9%$82.07 million$4.87 million-1.37
Myomo logo
MYO
Myomo
1.2$9.97-0.5%$55.94 million$3.84 million-1.09
Predictive Oncology logo
POAI
Predictive Oncology
1.3$0.94-11.1%$51.23 million$1.41 million-0.15News Coverage
Gap Up
AHPI
Allied Healthcare Products
0.5$4.20-5.5%$17.76 million$31.89 million0.00
NanoVibronix logo
NAOV
NanoVibronix
0.5$0.85-0.1%$11.39 million$530,000.00-1.42
Bionik Laboratories logo
BNKL
Bionik Laboratories
0.8$2.26-20.4%$11.31 million$2.15 million-0.46
Advanced Biomedical Technologies logo
ABMT
Advanced Biomedical Technologies
0.0$0.10-0.0%$7.09 million$10,000.000.00
AVTI
Avitar
0.5$0.00-0.0%$0.00N/A0.00
PFND
Pathfinder Cell Therapy
0.0$0.01-0.0%$0.00N/A0.00
PCGR
PC Group
0.2$0.00-0.0%$0.00N/A0.00
This page was last updated on 4/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.